Noosa News
Demand for weight-loss treatments opens new markets for Tasmania’s poppy industry
A shortage of the weight-loss drug Ozempic to treat type 2 diabetes has opened up new markets for the Tasmanian alkaloid poppy sector.
It’s the shot in the arm northern Tasmanian pharmaceutical business Extractas Bioscience needed.
For nearly a decade the poppy processor has struggled with a…
Continue Reading
-
Noosa News21 hours agoTerrifying break-in at childcare centre on Sunshine Coast ends with death of man
-
Noosa News19 hours agoADF to introduce billion-dollar drone dome over Brisbane 2032
-
Business20 hours agoInvested in IAG shares? Here are the key dates for FY26
-
General16 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine